Worldwide Flex transitioned two critical Phase III obsessive compulsive disorder (OCD) clinical registrational plus one long-term follow-up study for a mid-sized biotech. Using a rapid deployment of clinical research associates (CRAs), we delivered a complete monitoring team across multiple U.S. and Canada sites ensuring continuity and sponsor confidence. Worldwide Flex responded quickly to the sponsor’s needs, deploying CRAs across the North American within weeks of the contract’s execution.
Explore this case study to learn the impact of a fast, adaptable functional service provider (FSP) partnership in overcoming clinical trial challenges under tight timelines.
